Tong-Chuan He Selected Research

Mebendazole (Anti-Worm)

1/2021	Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways.
2/2017	Anthelmintic mebendazole enhances cisplatin's effect on suppressing cell proliferation and promotes differentiation of head and neck squamous cell carcinoma (HNSCC).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tong-Chuan He Research Topics

Disease

71	Neoplasms (Cancer) 12/2023 - 05/2002
23	Osteosarcoma (Osteogenic Sarcoma) 07/2020 - 05/2002
17	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 10/2002
16	Carcinogenesis 07/2023 - 12/2002
15	Colonic Neoplasms (Colon Cancer) 12/2021 - 10/2002
10	Neoplasm Metastasis (Metastasis) 11/2023 - 05/2002
6	Infections 12/2021 - 08/2003
5	Ovarian Neoplasms (Ovarian Cancer) 07/2023 - 12/2015
5	Melanoma (Melanoma, Malignant) 11/2022 - 04/2010
5	Wounds and Injuries (Trauma) 07/2022 - 12/2015
5	Hypoxia (Hypoxemia) 01/2021 - 01/2013
5	Breast Neoplasms (Breast Cancer) 01/2021 - 09/2008
4	Craniosynostoses (Craniosynostosis) 04/2023 - 06/2015
4	Intervertebral Disc Degeneration 01/2016 - 04/2003
3	Hepatocellular Carcinoma (Hepatoma) 07/2023 - 01/2011
3	Fibrosis (Cirrhosis) 09/2022 - 07/2018
3	Colitis 12/2015 - 06/2014
3	Sarcoma (Soft Tissue Sarcoma) 02/2013 - 08/2003
2	Hypertrophy 01/2024 - 06/2009
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2023 - 01/2020
2	Hypoglycemia (Reactive Hypoglycemia) 01/2023 - 01/2021
2	Adenoma (Adenomas) 11/2021 - 10/2002
2	Chondrosarcoma 11/2021 - 12/2018
2	Non-alcoholic Fatty Liver Disease 01/2020 - 12/2019
2	Obesity 12/2019 - 05/2012
2	Body Weight (Weight, Body) 12/2019 - 07/2013
2	Liver Diseases (Liver Disease) 04/2017 - 08/2013
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 02/2016 - 10/2002
2	Inflammation (Inflammations) 01/2015 - 07/2005
2	Glioma (Gliomas) 01/2014 - 03/2009
2	Bone Fractures (Bone Fracture) 08/2013 - 01/2013
2	Osteoporotic Fractures 11/2010 - 07/2010
2	Adenocarcinoma 02/2005 - 10/2002

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2002
15	CateninsIBA 10/2022 - 01/2011
6	Messenger RNA (mRNA)IBA 12/2018 - 10/2002
6	ginsenoside Rg3IBA 07/2013 - 12/2006
5	Long Noncoding RNAIBA 07/2023 - 08/2017
5	MicroRNAs (MicroRNA)IBA 12/2021 - 11/2015
5	protopanaxadiolIBA 01/2015 - 01/2013
5	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 06/2007
5	beta CateninIBA 07/2005 - 10/2002
4	CollagenIBA 01/2024 - 04/2003
4	Niclosamide FDA Link 07/2023 - 01/2015
4	NF-kappa B (NF-kB)IBA 04/2023 - 07/2003
4	AnthelminticsIBA 10/2022 - 01/2015
4	SaponinsIBA 07/2015 - 05/2008
4	Tuberculin (PPD)IBA 01/2015 - 01/2013
4	Retinoid X Receptors (Retinoid X Receptor)IBA 07/2012 - 05/2002
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2012 - 05/2002
4	PPAR gammaIBA 04/2010 - 05/2002
4	Small Interfering RNA (siRNA)IBA 03/2009 - 08/2003
3	Monensin (Coban)IBA 12/2023 - 12/2015
3	Transcription Factors (Transcription Factor)IBA 11/2023 - 01/2014
3	Cisplatin (Platino)FDA LinkGeneric 07/2023 - 02/2017
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 02/2011
3	RNA (Ribonucleic Acid)IBA 07/2020 - 03/2018
3	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2020 - 01/2007
3	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 12/2002
3	LigandsIBA 01/2015 - 05/2002
2	Collagen Type XIBA 01/2024 - 06/2009
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 12/2015
2	GlycogenIBA 07/2023 - 01/2023
2	EnzymesIBA 01/2023 - 01/2021
2	CalciumIBA 01/2023 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2013
2	Casein Kinases (Casein Kinase)IBA 10/2022 - 02/2016
2	LuciferasesIBA 12/2021 - 01/2017
2	Small Nucleolar RNA (snoRNA)IBA 11/2021 - 01/2021
2	Mebendazole (Anti-Worm)FDA Link 01/2021 - 02/2017
2	PlatinumIBA 01/2021 - 01/2020
2	Oleic Acid (Oleate)IBA 01/2020 - 12/2019
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2018 - 01/2016
2	Bone Morphogenetic Protein 2IBA 01/2017 - 09/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 01/2015
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2015 - 11/2011
2	Calcium-Binding ProteinsIBA 01/2015 - 01/2013
2	AzoxymethaneIBA 01/2015 - 06/2014
2	GenisteinIBA 07/2013 - 01/2013
2	trichrome stainIBA 02/2013 - 06/2007
2	panaxadiolIBA 02/2013 - 05/2012
2	GinsenosidesIBA 01/2013 - 09/2008
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013 - 02/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 10/2007
2	tetrandrineIBA 01/2013 - 02/2011
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 07/2012 - 04/2010
2	AntioxidantsIBA 02/2011 - 03/2010
2	Cyclin D1IBA 01/2011 - 10/2002
2	Troglitazone (Rezulin)FDA Link 04/2010 - 05/2002
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2007 - 05/2002
2	Methylnitronitrosoguanidine (MNNG)IBA 01/2005 - 05/2002

Therapy/Procedure

35	Therapeutics 01/2023 - 05/2002
8	Drug Therapy (Chemotherapy) 03/2022 - 01/2010
4	Sutures (Suture) 01/2020 - 03/2011
2	Radiotherapy 03/2022 - 01/2010
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2020 - 11/2009
2	Denervation 10/2015 - 05/2013
2	Chemoprevention 01/2015 - 01/2013
2	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2013 - 06/2009
2	Spinal Fusion (Spondylosyndesis) 08/2013 - 11/2005